We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
-1.2%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.88B
AUM Growth
+$134M
Cap. Flow
+$219M
Cap. Flow %
5.65%
Top 10 Hldgs %
22.53%
Holding
368
New
30
Increased
108
Reduced
154
Closed
12

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$51M
2
CB icon
Chubb
CB
+$44M
3
ABT icon
Abbott
ABT
+$37.6M
4
AFL icon
Aflac
AFL
+$31M
5
T icon
AT&T
T
+$16.9M

Top Sells

Rank Stock Value
1
EACQ
Easterly Acquisition Corp
EACQ
+$10M
2
CVS icon
CVS Health
CVS
+$6.32M
3
SRCL
Stericycle Inc
SRCL
+$4.84M
4
HEDJ icon
WisdomTree Europe Hedged Equity Fund
HEDJ
+$4.74M
5
XOM icon
ExxonMobil
XOM
+$4.59M

Sector Composition

Rank Sector Weight
1 Healthcare 19.2%
2 Technology 17.48%
3 Financials 12.88%
4 Industrials 9.97%
5 Consumer Discretionary 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.B icon
76
Berkshire Hathaway Class B
BRK.B
$1.1T
$17.3M 0.45%
86,657
-1,512
-2% -$310K
BDX icon
77
Becton Dickinson
BDX
$45.6B
$17.1M 0.44%
80,997
+980
+1% +$215K
T icon
78
AT&T
T
$159B
$16.4M 0.42%
+607,255
New +$16.9M
IBM icon
79
IBM
IBM
$209B
$16M 0.41%
109,178
-3,117
-3% -$472K
GE icon
80
GE Aerospace
GE
$368B
$15.3M 0.4%
237,587
-42,073
-15% -$3.12M
EW icon
81
Edwards Lifesciences
EW
$50B
$14.7M 0.38%
315,921
-1,830
-0.6% -$79.5K
BMY icon
82
Bristol-Myers Squibb
BMY
$132B
$14.5M 0.37%
229,778
-254
-0.1% -$16.3K
CMI icon
83
Cummins
CMI
$87.3B
$14.4M 0.37%
88,945
+4,102
+5% +$705K
MIDD icon
84
Middleby
MIDD
$6.03B
$13.7M 0.35%
110,559
-4,754
-4% -$623K
VEA icon
85
Vanguard FTSE Developed Markets ETF
VEA
$230B
$13.1M 0.34%
295,095
+3,814
+1% +$173K
MZTI
86
The Marzetti Company
MZTI
$2.95B
$12.8M 0.33%
104,215
-1,069
-1% -$132K
SU icon
87
Suncor Energy
SU
$78.8B
$12.4M 0.32%
360,067
-747
-0.2% -$26K
GILD icon
88
Gilead Sciences
GILD
$163B
$11.7M 0.3%
155,667
-1,929
-1% -$153K
VWO icon
89
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$11.5M 0.3%
243,857
+27,679
+13% +$1.33M
SYY icon
90
Sysco
SYY
$40.6B
$11.4M 0.29%
190,612
-8,023
-4% -$486K
EMR icon
91
Emerson Electric
EMR
$83.3B
$11.4M 0.29%
167,178
-3,725
-2% -$265K
CHKP icon
92
Check Point Software Technologies
CHKP
$13.1B
$11.3M 0.29%
+113,269
New +$11.7M
LLY icon
93
Eli Lilly
LLY
$1.03T
$11.2M 0.29%
144,287
-1,681
-1% -$135K
BSX icon
94
Boston Scientific
BSX
$68.4B
$10.9M 0.28%
397,589
-4,581
-1% -$125K
WMT icon
95
Walmart Inc
WMT
$884B
$10.7M 0.28%
362,112
-1,836
-0.5% -$59.1K
MDT icon
96
Medtronic
MDT
$110B
$9.78M 0.25%
+121,904
New +$10.1M
QCOM icon
97
Qualcomm
QCOM
$160B
$9.74M 0.25%
175,713
-3,662
-2% -$233K
BEN icon
98
Franklin Resources
BEN
$17.2B
$9.35M 0.24%
269,632
-25,923
-9% -$1.05M
SBUX icon
99
Starbucks
SBUX
$121B
$9.3M 0.24%
160,677
+14,895
+10% +$861K
LECO icon
100
Lincoln Electric
LECO
$13.7B
$9.28M 0.24%
103,165
+8,974
+10% +$836K
2 3
4
5 6

Similar funds

OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Welch & Forbes's Q1 2018 Portfolio in Review

As of Q1 2018, Welch & Forbes held 368 positions worth $3.88B, up 3.6% from $3.75B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Welch & Forbes deployed $219M of net new capital in Q1 2018, opening 30 new positions and adding to 108 existing holdings. Its largest new stake was AbbVie: 464,710 shares worth $44M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was CVS Health, an estimated $6.32M trimmed.

  • Welch & Forbes's largest Q1 2018 buy was AbbVie: 464,710 shares worth $44M.
  • Welch & Forbes added most to Johnson & Johnson in Q1 2018, an estimated $8.9M increase.
  • Welch & Forbes's biggest Q1 2018 reduction was CVS Health, cutting an estimated $6.32M.
  • Welch & Forbes fully exited Easterly Acquisition Corp in Q1 2018, selling an estimated $10M.
  • Welch & Forbes's ten largest holdings make up 23% of its $3.88B portfolio in Q1 2018.
  • Welch & Forbes opened 30 new positions and closed 12 in Q1 2018.
  • Welch & Forbes's portfolio value rose 3.6% quarter-over-quarter to $3.88B.

Based on Welch & Forbes's 13F filing for Q1 2018, filed 12 Apr 2018.